FDA Panel OK’s Johnson & Johnson Single-Dose COVID-19 Vaccine

New York Post

A panel of expert advisers to the US Food and Drug Administration on Friday recommended that the agency approve the use of Johnson & Johnson’s single-dose COVID-19 vaccine — clearing a path for the shot to be rolled out across the country.

The FDA is likely to authorize the vaccine within the coming days. Once approved, the shot would be the third COVID-19 vaccine available in the US, after the two-dose vaccines made by Pfizer and Moderna.

The FDA panelists voted unanimously that the benefits of the Johnson & Johnson vaccine outweighed any risks.

Read More at the New York Post

Be the first to comment!

The comment must be no longer than 400 characters 0/400